Back to results
US 2026/0271985 A1Published application
Oral Formulations of Kava and Nicotine
OwnerJerry Wayne Rossinventor
Life of this patent
Estimating the term…
Abstract
Disclosed herein are oral formulations comprising a nicotine composition and/or a kava composition. The oral formulations comprising a nicotine composition and/or a kava composition disclosed herein may be formulated as a chewable tablet, a lozenge, a chewing gum, a dissolvable oral strip, or a pouch. Also disclosed herein are methods for making a chewable tablet, a lozenge, a chewing gum, a dissolvable oral strip, or a pouch comprising a nicotine composition and/or a kava composition.
Claims18
A composition comprising an amount of kavalactones;
- wherein the amount of kavalactones is between about 50 mg and about 900 mg;
- wherein the kavalactones comprise kavain, dihydrokavain, and optionally, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin;
- wherein the composition is substantially free of flavokavain A and flavokavain B;
- and
- wherein the composition is formulated as a paste.
2 more elements
Dependencies are inferred from the claim text.